INSULIN Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, INSULIN Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Finance.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title; table of contents This Act may be cited as the Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 or the INSULIN Act...
- Section id2558cd0ea5c64f1698c0a0a77ca5bd73: 2. Sense of Congress It is the sense of Congress that Congress should enact subsequent legislation that provides for an offset for any costs to the Federal...
- Section idCEDB8684E0CC4711B21D98964E244D42: 101. Requirements with respect to cost-sharing for certain insulin products Part D of title XXVII of the Public Health Service Act (42 U.S.C. 300gg–111 et...
- Section id94C16274D9924631AE4DC39E0F30D09B: 2799A–12. Requirements with respect to cost-sharing for certain insulin products For plan years beginning on or after January 1, 2027, a group health plan or...
- Section H7E90B73D642B4EE18F2929A0DA67288E: 727. Requirements with respect to cost-sharing for certain insulin products For plan years beginning on or after January 1, 2027, a group health plan or health...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, INSULIN Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Finance
Primary Purpose
This bill, INSULIN Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeRead twice and referred to the Committee on Health, Education, …
Introduced in Senate
Mrs. Shaheen (for herself, Ms. Collins, Mr. Warnock, Mr. Kennedy, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "the_administrator"
- → The Administrator identified in the operative section
- "secretary_of_labor"
- → Secretary of Labor
- "secretary_of_treasury"
- → Secretary of the Treasury
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
an individual who— is a citizen of the United States or a qualified alien (as defined in section 431(b) of the Personal Responsibility and Work Opportunity Reconciliation Act of 1996)
insulin that is licensed under subsection (a) or (k) of section 351 of the Public Health Service Act (42 U.S.C. 262) and continues to be marketed pursuant to such licensure
an individual who— is a citizen of the United States or a qualified alien (as defined in section 431(b) of the Personal Responsibility and Work Opportunity Reconciliation Act of 1996)
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology